s6y
Company name or ticker
Search
Neumora Therapeutics, Inc.
DEF 14A
Definitive proxy statements
Filed
Friday, April 17, 2026
Period
May 27, 2026
Accession number
0001193125-26-161489
Documents
DEF 14A
DEF 14A
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
EX-101.SCH
On sec.gov
Filing index
All files
Complete submission text
SGML header